Pharming PHAR
NASDAQ PHAR
$9.66 -0.09 (-0.94%)
As of: Oct 21, 2026 · 1:23 PM EDT

Pharming (PHAR) Notes Payables (2024)

Updated

Analysis

Pharming (PHAR) Notes Payables (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn
10 Pharming 665.36 Mn -129.01 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.25 Mn
API Access

Pharming Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=PHAR&period=max&api_key=YOUR_API_KEY